It has already been established that in end-stage renal disease, hyperphosphatemia causes
soft tissue calcification including vascular calcifications. It has also been supported that there …

High serum phosphate is linked to poor health outcome and mortality in chronic kidney
disease (CKD) patients before or after the initiation of dialysis. Therefore, maintenance of …

There is an intimate association between mineral and bone disorders in chronic kidney
disease (CKD) and the extensive burden of cardiovascular disease (CVD) in this population …

A complex system of endocrine and paracrine signals exists to control phosphate balance.
Dysregulation of these systems in patients with chronic kidney disease has serious clinical …

Background Serum phosphate is a known risk factor for cardiovascular events and mortality
in people with chronic kidney disease (CKD), however data on the association of these …

Background High serum phosphorus levels are associated with cardiovascular morbidity
and mortality in kidney disease. Although serum phosphorus levels possibly influence on …

Background. Elevations in serum phosphorus are associated with renal decline in animal
models and progression of established chronic kidney disease (CKD) in human …

Abstract Background and Aim: Due to increasing evidence suggesting a link between
hyperphosphatemia and cardiovascular disease (CVD), mediated through vascular …

Background The association between elevated serum phosphorus concentration and
cardiovascular or all-cause mortality yielded conflicting results. Objective To assess the …

Chronic kidney disease (CKD) is prevalent affecting 8.5% of the population in the UK and it
is associated with premature cardiovascular disease (CVD) and death. The association …